TVGN — Tevogen Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1860871 ·
Last close
$5.69
Market Cap
$37.05M
52W High
$24.90
52W Low
$3.64
ADV30
9,282
Next earnings
2026-11-16

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -5,662,376 -5,761,940 4,727,741 1,082,155 13,616,501
Mar 2026 0 — -5,400,920 -5,446,255 4,921,005 692,305 14,763,163
Dec 2025 0 — -4,610,201 -4,677,580 4,382,994 552,372 12,617,720
Sep 2025 0 — -5,729,431 -5,726,812 4,493,669 1,037,094 12,317,565

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-11,569,983
Investing CF
$-64,439
Financing CF
$12,031,348
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6.34
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-150,868,744
Inventory
—
Receivables
$158,819
ST Investments
—
EBIT TTM
$-21,308,843
Pretax Income TTM
$-21,612,587
Interest Exp TTM
$228,751
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -26,140,515 -26,275,432 4,382,994 12,617,720 -8,234,726 -12,328,577
Dec 2024 0 -53,564,488 -13,727,380 3,461,675 10,135,680 -6,674,005 -11,998,730
Dec 2023 0 -8,843,025 -60,477,680 5,505,503 99,934,400 -94,428,897 -8,171,118
Dec 2022 0 -953,083 4,408,361 357,138,356 15,057,704 342,080,652 -215,395
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-21,612,587
OpCashFlow TTM
—
Assets (Latest)
$4,727,741
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
CRBU Caribou Biosciences, Inc. $36.81M $0.34 —
TIL Instil Bio, Inc. $36.62M $5.40 —
ELUT ELUTIA INC. $37.91M $0.85 —
BKHA Black Hawk Acquisition Corp $35.93M $8.65 —
KLRS Kalaris Therapeutics, Inc. $34.04M $1.43 —

News headlines (Yahoo Finance, 1h cache)

Tevogen Highlights Significant Liability Reduction and Continued Insider Control
2026-11-18 19:30 · Yahoo
Tevogen Complements Capital Access with Two-Year Extension to Loan Agreement
2026-11-09 13:05 · Yahoo
UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
2026-10-08 19:50 · Yahoo
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
2026-10-08 18:10 · Yahoo
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
2026-09-30 20:30 · Yahoo
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
2026-07-29 12:00 · Yahoo
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
2026-07-14 02:15 · Yahoo
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
2026-05-21 16:15 · Yahoo
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
2026-05-12 15:45 · Yahoo
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
2026-05-28 16:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.